Prostate Cancer Foundation, Santa Monica, CA 90401, USA.
Cancer Res. 2013 Aug 15;73(16):4988-91. doi: 10.1158/0008-5472.CAN-12-4576. Epub 2013 Mar 27.
Prostate Cancer Foundation (PCF) convened its 19th Annual Scientific Retreat October 25-27, 2012, in Carlsbad, CA. Each year, this event brings together diverse researchers in a collaborative forum to present and discuss new and largely unpublished findings for prostate cancer diagnosis, prognosis, and treatment and defines the challenges to ending this disease as a threat to life and well-being. Several themes resonated at the multidisciplinary meeting, notably (i) the roles of field cancerization, tumor microenvironment, epithelial plasticity, signal transduction pathways in cancer progression, and disease resistance; (ii) intratumoral heterogeneity and consequences for precision medicine; (iii) resistance mechanisms to androgen axis inhibitors; and (iv) advances in molecular imaging and therapeutics for better detection and treatment.
前列腺癌基金会 (PCF) 于 2012 年 10 月 25 日至 27 日在加利福尼亚州卡尔斯巴德召开了第 19 届年度科学务虚会。每年,该活动都会汇集不同领域的研究人员,以协作论坛的形式展示和讨论前列腺癌诊断、预后和治疗方面的新的和主要未发表的发现,并确定消除这种疾病对生命和健康的威胁所面临的挑战。在这次多学科会议上,有几个主题引起了共鸣,特别是:(i) 癌灶内异质性及其对精准医疗的影响;(ii) 肿瘤微环境、上皮可塑性、信号转导通路在癌症进展中的作用,以及疾病耐药性;(iii) 针对雄激素轴抑制剂的耐药机制;(iv) 分子成像和治疗的进展,以更好地进行检测和治疗。